The American Society of Clinical Oncology (ASCO) meeting is scheduled for 1st - 5th June 2012 in Chicago. Apparently, it is a huge event (drawing an estimated 25,000 physicians) and showcases new and emerging procedures in the treatment of cancer.
Whilst researching the ASCO site I came across an Abstract for CVac which can be found at:
http://abstract.asco.org/AbstView_114_100245.html
"A study of autologous dendritic cell therapy targeting muchin-1 for treatment of patients with epithelial ovarian cancer in first remission."
The full Abstract can be found at the link above.
I'm assuming (but I can't confirm from the ASCO site) that a representative from PrimaBiomed will be present during the Category Session - Gynecological Cancer which is scheduled for Sunday, 3rd June 2012 between 8am and 12pm.
This seems to me to be a very positive initiative by Prima and will give the CANVAS trial a higher profile among physicians in the USA and beyond.
Regards,
Goggo
american society of clinical oncology (asco)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |